NCT06244056

Brief Summary

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
108

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Feb 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

February 5, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

February 6, 2024

Status Verified

February 1, 2024

Enrollment Period

11 months

First QC Date

November 17, 2023

Last Update Submit

February 2, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of left ventricular ejection fraction (LVEF).

    Change of left ventricular ejection fraction (LVEF).

    3 month

  • Change of NYHA classification.

    Change of NYHA classification.

    3 month

Secondary Outcomes (4)

  • Change of 6 minutes walking test.

    3 month

  • Heart failure hospitalization.

    3 month

  • Vascular complications and safety issues.

    3 month

  • Cardiovascular death.

    3 month

Study Arms (3)

Narrow QRS complex Heart failure patients

NO INTERVENTION

Narrow QRS complex Heart failure patients with optimal medical treatment.

: Narrow QRS complex Heart failure patients

ACTIVE COMPARATOR

: Narrow QRS complex Heart failure patients with optimal medical treatment with stellate ganglion block.

Procedure: Stellate Ganglion Block

Wide QRS complex heart failure patients

ACTIVE COMPARATOR

Wide QRS complex heart failure patients with optimal medical treatment who were non responders to CRT( retrospective and prospective) with stellate ganglion block.

Procedure: Stellate Ganglion Block

Interventions

A stellate ganglion block is performed by a medical professional in a sterile setting. Firstly Position of patient: Semi-lateral decubitus position, with the neck turned contralateral. Using Probe of ultrasound: Linear 6-13 MHz to guide the needle to the stellate ganglion , The skin at the injection site is cleaned with an antiseptic solution to reduce the risk of infection. A local anesthetic is injected into the skin and deeper tissues to numb the area. Needle:25G 1.5 inch or 22G 3.5 inch is inserted through the skin and deeper tissues until it reaches the stellate ganglion.Once the needle is in the correct position, 3-5 mL of local anesthetic (0.25-0.5% bupivacaine) The procedure typically takes about 15-20 minutes.

: Narrow QRS complex Heart failure patientsWide QRS complex heart failure patients

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 : 70 years old.
  • NYHA Class III-IV Heart Failure.
  • Heart failure with a reduced ejection fraction (HFrEF) LVEF ≤ 40% calculated using 2D echocardiography and Biplane Simpson's .
  • Optimal tolerated Medical Therapy for Heart Failure.

You may not qualify if:

  • Active Malignancy.
  • Acute heart failure including pulmonary edema or cardiogenic shock.
  • Severe, life-threatening non-cardiac disease.
  • Pregnancy.
  • Localized infection.
  • Coagulopathy or anticoagulated patients.
  • Refused this procedure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Assiut University

Asyut, 71515, Egypt

NOT YET RECRUITING

Assiut university

Asyut, 71515, Egypt

RECRUITING

Central Study Contacts

Mina Fam, Resident

CONTACT

Aly Tohamy, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A stellate ganglion block is performed by a medical professional in a sterile setting. Firstly Position of patient: Semi-lateral decubitus position, with the neck turned contralateral. Using Probe of ultrasound: Linear 6-13 MHz to guide the needle to the stellate ganglion , The skin at the injection site is cleaned with an antiseptic solution to reduce the risk of infection. A local anesthetic is injected into the skin and deeper tissues to numb the area. Needle:25G 1.5 inch or 22G 3.5 inch is inserted through the skin and deeper tissues until it reaches the stellate ganglion.Once the needle is in the correct position, 3-5 mL of local anesthetic (0.25-0.5% bupivacaine) The procedure typically takes about 15-20 minutes.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

November 17, 2023

First Posted

February 6, 2024

Study Start

February 5, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

February 6, 2024

Record last verified: 2024-02

Locations